Literature DB >> 28138581

Is the transthoracic approach no longer a viable option for Siewert type II esophagogastric junction carcinoma?

Hiroharu Yamashita1, Yasuyuki Seto1.   

Abstract

Entities:  

Year:  2016        PMID： 28138581      PMCID： PMC5244694          DOI： 10.21037/tgh.2016.03.07

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  15 in total

1.  Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification.

Authors:  Yun-Suhk Suh; Dong-Seok Han; Seong-Ho Kong; Hyuk-Joon Lee; Young Tae Kim; Woo-Ho Kim; Kuhn Uk Lee; Han-Kwang Yang
Journal:  Ann Surg       Date:  2012-05       Impact factor: 12.969

2.  Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial.

Authors:  Mitsuru Sasako; Takeshi Sano; Seiichiro Yamamoto; Motonori Sairenji; Kuniyoshi Arai; Taira Kinoshita; Atsushi Nashimoto; Masahiro Hiratsuka
Journal:  Lancet Oncol       Date:  2006-08       Impact factor: 41.316

3.  Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients.

Authors:  Jeremiah T Martin; Angela Mahan; Joseph B Zwischenberger; Patrick C McGrath; Ching-Wei D Tzeng
Journal:  J Am Coll Surg       Date:  2014-12-29       Impact factor: 6.113

4.  Oesophagogastric junction adenocarcinoma: which therapeutic approach?

Authors:  Christophe Mariette; Guillaume Piessen; Nicolas Briez; Caroline Gronnier; Jean Pierre Triboulet
Journal:  Lancet Oncol       Date:  2010-11-23       Impact factor: 41.316

5.  Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.

Authors:  Hiroharu Yamashita; Hitoshi Katai; Shinji Morita; Makoto Saka; Hirokazu Taniguchi; Takeo Fukagawa
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

6.  Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype.

Authors:  Ana Ferro; Bárbara Peleteiro; Matteo Malvezzi; Cristina Bosetti; Paola Bertuccio; Fabio Levi; Eva Negri; Carlo La Vecchia; Nuno Lunet
Journal:  Eur J Cancer       Date:  2014-03-17       Impact factor: 9.162

7.  Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes.

Authors:  Christian G Peyre; Jeffrey A Hagen; Steven R DeMeester; Jan J B Van Lanschot; Arnulf Hölscher; Simon Law; Alberto Ruol; Ermanno Ancona; S Michael Griffin; Nasser K Altorki; Thomas W Rice; John Wong; Toni Lerut; Tom R DeMeester
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

8.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.

Authors:  Jan B F Hulscher; Johanna W van Sandick; Angela G E M de Boer; Bas P L Wijnhoven; Jan G P Tijssen; Paul Fockens; Peep F M Stalmeier; Fiebo J W ten Kate; Herman van Dekken; Huug Obertop; Hugo W Tilanus; J Jan B van Lanschot
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

9.  A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database.

Authors:  Hiroya Takeuchi; Hiroaki Miyata; Mitsukazu Gotoh; Yuko Kitagawa; Hideo Baba; Wataru Kimura; Naohiro Tomita; Tohru Nakagoe; Mitsuo Shimada; Kenichi Sugihara; Masaki Mori
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

10.  Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia.

Authors:  Y Kurokawa; M Sasako; T Sano; T Yoshikawa; Y Iwasaki; A Nashimoto; S Ito; A Kurita; J Mizusawa; K Nakamura
Journal:  Br J Surg       Date:  2015-01-21       Impact factor: 6.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.